Edwards Lifesciences/EW
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Edwards Lifesciences
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Ticker
EW
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Irvine, United States
Employees
19,800
Website
www.edwards.com
EW Metrics
BasicAdvanced
$54B
Market cap
38.90
P/E ratio
$2.32
EPS
1.10
Beta
-
Dividend rate
Price and volume
Market cap
$54B
Beta
1.1
Financial strength
Current ratio
3.755
Quick ratio
2.318
Long term debt to equity
9.384
Total debt to equity
9.729
Interest coverage (TTM)
100.68%
Management effectiveness
Return on assets (TTM)
12.05%
Return on equity (TTM)
21.28%
Valuation
Price to earnings (TTM)
38.9
Price to revenue (TTM)
8.89
Price to book
7.62
Price to tangible book (TTM)
10.03
Price to free cash flow (TTM)
217.44
Growth
Revenue change (TTM)
11.68%
Earnings per share change (TTM)
-3.77%
3-year revenue growth
11.15%
3-year earnings per share growth
19.81%
What the Analysts think about EW
Analyst Ratings
Majority rating from 32 analysts.
EW Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.6B
4.18%
Net income
$352M
-4.87%
Profit margin
22.01%
-8.71%
EW Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.66
$0.59
$0.64
$0.66
-
Expected
$0.65
$0.59
$0.64
$0.64
$0.69
Surprise
2.03%
-0.40%
0.41%
2.68%
-
EW News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Edwards Lifesciences stock?
Edwards Lifesciences (EW) has a market cap of $54B as of July 03, 2024.
What is the P/E ratio for Edwards Lifesciences stock?
The price to earnings (P/E) ratio for Edwards Lifesciences (EW) stock is 38.9 as of July 03, 2024.
Does Edwards Lifesciences stock pay dividends?
No, Edwards Lifesciences (EW) stock does not pay dividends to its shareholders as of July 03, 2024.
When is the next Edwards Lifesciences dividend payment date?
Edwards Lifesciences (EW) stock does not pay dividends to its shareholders.
What is the beta indicator for Edwards Lifesciences?
Edwards Lifesciences (EW) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Edwards Lifesciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.